Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

08-07-2021 | Original Paper

COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study

Auteurs: Israel Krieger, Galit Erez, Orly Weinstein, Arnon Dov Cohen, Dana Tzur Bitan

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 2/2023

Abstract

In this study we aimed to assess whether individuals with ASD are prone to higher infection rates, or to severe COVID-19 illness. Individuals with ASD and age- and gender-matched controlled counterparts (total n = 32,812) were assessed for COVID-19 infection rates and hospitalizations. Results indicated higher infection rates among individuals with ASD, with the largest effect among individuals aged 40–60 (OR = 2.05, 95%CI 1.33–3.15, p < .001), as well as higher odds for hospitalizations, evident primarily in men (OR = 2.40, 95%CI 1.14–5.02, p = 0.02) but not women. Medical and environmental risk factors may associate ASD with higher infection and morbidity rates. Healthcare policy providers should consider proactive steps to protect this population from the associated risks.

vorige artikel Newborn Auditory Brainstem Responses in Children with Developmental Disabilities

volgende artikel “Sometimes I Feel Grateful…”: Experiences of the Adolescent Siblings of Children with Autism Spectrum Disorder in Malaysia

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders. American Psychiatric Association.CrossRef

Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water J. (2011). Altered T cell responses in children with autism. Brain Behaviour and Immunity, 25, 840–849

Christensen, D. L., Braun, K. V. N., Baio, J., Bilder, D., Charles, J., Constantin, J. N., Daniels, J., Durkin, M. S., Fitzgerald, R. T., Kurzius-Spencer, M., Pettygrove, S. D., Robinson, C., Shenouda, J., White, T., Zahorodny, W., Pazol, K., & Dietz, P. (2019). Prevalence and characteristics of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveillance Summaries, 68(2), 1.CrossRefPubMedCentral

Conti, P., Ronconi, G., Caraffa, A. L., Gallenga, C. E., Ross, R., Frydas, I., & Kritas, S. K. (2020). Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): Anti-inflammatory strategies. Journal of Biological Regulators and Homeostatic Agents, 34(2), 1.PubMed

de Sousa Lima, M. E., Barros, L. C. M., & Aragão, G. F. (2020). Could autism spectrum disorders be a risk factor for COVID-19? Medical Hypotheses, 144, 109899.CrossRef

Eshraghi, A. A., Li, C., Alessandri, M., Messinger, D. S., Eshraghi, R. S., Mittal, R., & Armstrong, F. D. (2020). COVID-19: Overcoming the challenges faced by individuals with autism and their families. The Lancet Psychiatry., 7(6), 481–483.CrossRefPubMedPubMedCentral

Filiano, A. J., Xu, Y., Tustison, N. J., Marsh, R. L., Baker, W., Smirnov, I., Overall, C. C., Gadani, S. P., Turner, S. D., Weng, Z., Peerzade, S. N., Chen, H., Lee, K. S., Scott, M. M., Beenhakker, M. P., Litvak, V., & Kipnis, J. (2016). Unexpected role of interferon-c in regulating neuronal connectivity and social behaviour. Nature, 535, 425–429.CrossRefPubMedPubMedCentral

Friedman, M. Y., Leventer-Roberts, M., Rosenblum, J., Zigman, N., Goren, I., Mourad, V., Lederman, N., Cohen, N., Matz, E., Dushnitzky, D. Z., Borovsky, N., Hoshen, M. B., Focht, G., Avitzour, M., Shachar, Y., Chowers, Y., Eliakim, R., Ben-Horin, S., Odes, S., … Turner, D. (2018). Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: An epi-IIRN group study. Clinical Epidemiology, 10, 671–681.CrossRefPubMedPubMedCentral

Geldsetzer, P., Manne-Goehler, J., Theilmann, M., Davies, J. I., Awasthi, A., Vollmer, S., Jaacks, L. M., Bärnighausen, T., & Atun, R. (2018). Diabetes and hypertension in India: A nationally representative study of 1.3 million adults. JAMA Internal Medicine, 178(3), 363–372.CrossRefPubMedPubMedCentral

Gurdasani, D., Alwan, N. A., Greenhalgh, T., Hyde, Z., Johnson, L., McKee, M., Michie, S., Prather, K. A., Rasmussen, S. D., Reicher, S., Roderick, P., & Ziauddeen, H. (2021). School reopening without robust COVID-19 mitigation risks accelerating the pandemic. The Lancet, 397(10280), 1177–1178.CrossRef

Krieger, I., Grossman-Giron, A., Comaneshter, D., Weinstein, O., Kridin, K., Cohen, A., & Bitan, D. T. (2021). The co-occurrence of autistic spectrum disorder and schizophrenia: A nationwide population-based study. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2021.04.012CrossRefPubMed

Krieger, I., Tzur Bitan, D., Comaneshter, D., Cohen, A., & Feingold, D. (2019). Increased risk of smoking-related illnesses in schizophrenia patients: A nationwide cohort study. Schizophrenia Research, 212, 121–125.CrossRefPubMed

Lessler, J., Grabowski, M. K., Grantz, K. H., Badillo-Goicoechea, E., Metcalf, C. J. E., Lupton-Smith, C., Azman, A. S., & Stuart, E. A. (2021). Household COVID-19 risk and in-person schooling. MedRxiv. https://doi.org/10.1101/2021.02.27.21252597 published online March 1 (preprint).CrossRefPubMedPubMedCentral

Li, J., Huang, D. Q., Zou, B., Yang, H., Hui, W. Z., Rui, F., Yee, N. T., Liu, C., Nerurkar, S. N., Kai, J. C., & Teng, M. L. (2020). Epidemiology of COVID-19: A systematic review and meta- analysis of clinical characteristics, risk factors, and outcomes. Journal of Medical Virology, 93, 1–10.

Ministry of Health (I). (2021, February) COVID-19 vaccinations to children at the ages of 12–15: Special cases. Document number: 166847121.

Ministry of Health (II). (2018). Annual report of healthcare‐providing companies for 2018. https://www.health.gov.il/PublicationsFiles/dochHashvaatui2018.pdf. Accessed 19 April 2021.

Peckham, H., Gruijter, N., Raine, C., Radziszewska, A., Ciurtin, C., Wedderburn, L. R., Rosser, E. C., Deakin, C. T., & Webb, K. (2020). Sex-bias in COVID-19: A meta-analysis and review of sex differences in disease and immunity. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3572881CrossRef

Qian, G., Yang, N., Ma, A. H. Y., Wang, L., Li, G., Chen, X., et al. (2020). COVID-19 transmission within a family cluster by presymptomatic carriers in China. Clinical Infectious Diseases, 71(15), 861–862.CrossRefPubMedPubMedCentral

Reges, O., Weinberg, H., Hoshen, M., Greenland, P., Rayyan-Assi, H. A., Tsadok, M. A., et al. (2020). Combining inpatient and outpatient data for diagnosis of non-valvular atrial fibrillation using electronic health records: A validation study. Clinical Epidemiology, 12, 477–483.CrossRefPubMedPubMedCentral

Rennert, G., & Peterburg, Y. (2001). Prevalence of selected chronic diseases in Israel. The Israel Medical Association Journal, 3, 404–408.PubMed

Shalom, G., Magen, E., Babaev, M., Tiosano, S., Vardy, D. A., Linder, D., et al. (2018). Chronic urticaria and the metabolic syndrome: A cross-sectional community-based study of 11 261 patients. Journal of the European Academy of Dermatology and Venereology, 32, 276–281.CrossRefPubMed

Tzur Bitan, D., Krieger, I., Kridin, K., Komantscher, D., Scheinman, Y., Weinstein, O., Cohen, A. D., Cicurel, A. A., & Feingold, D. (2021). COVID-19 prevalence and mortality among schizophrenia patients: a large-scale retrospective cohort study. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbab012CrossRefPubMedPubMedCentral

Vahidy, F. S., Pan, A. P., Ahnstedt, H., Munshi, Y., Choi, H. A., Tiruneh, Y., Nasir, K., Kash, B. A., Andrieni, J. D., & McCullough, L. D. (2021). Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area. PLoS One, 16(1), e0245556.CrossRefPubMedPubMedCentral

Zhou, Y., Chi, J., Lv, W., & Wang, Y. (2021). Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes/Metabolism Research and Reviews, 37(2), e3377.CrossRefPubMed

Titel: COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study
Auteurs: Israel Krieger
Galit Erez
Orly Weinstein
Arnon Dov Cohen
Dana Tzur Bitan
Publicatiedatum: 08-07-2021
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 2/2023
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-021-05187-2

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 2/2023

Autistic Traits in the Neurotypical Chinese Population: A Chinese Version of Glasgow Sensory Questionnaire and a Cross-Cultural Difference in Attention-to-Detail

Effect of Co-occurring Psychiatric Disorders on Treatment of Children with Autism Spectrum Disorder and Anxiety

Promoting Positive Health Outcomes in an Urban Community-Based Physical Activity Intervention for Preschool Aged Children on the Autism Spectrum

Group Based Cognitive Behavioural Therapy for Anxiety in Children with Autism Spectrum Disorder: A Randomised Controlled Trial in a General Child Psychiatric Hospital Setting

“Sometimes I Feel Grateful…”: Experiences of the Adolescent Siblings of Children with Autism Spectrum Disorder in Malaysia

Changes in Attitudes and Knowledge after Trainings in a Clinical Care Pathway for Autism Spectrum Disorder